Strategic guidance from
proven professionals

Rebekah Schulz, Ph.D.

Specialist, Project Management and Clinical Pharmacology

Dr. Schulz received her Ph.D. from the University of North Carolina, where her work focused on investigating the cellular mechanism of a novel immune-agonizing microparticle delivery platform for cancer therapy. Prior to joining Nuventra, Dr. Schulz was a regulatory affairs intern at Cato Research, where she worked on clinical trial deliverables for a wide range of disease interests.

Education

  • Doctor of Philosophy, Genetics and Molecular Biology
    • University of North Carolina, Chapel Hill, NC
  • Bachelor of Science, Biochemistry and Nanoscience
    • Virginia Tech, Blacksburg, VA